Search

Your search keyword '"Thomas P Monath"' showing total 349 results

Search Constraints

Start Over You searched for: Author "Thomas P Monath" Remove constraint Author: "Thomas P Monath"
349 results on '"Thomas P Monath"'

Search Results

301. Pathobiology of the Flaviviruses

302. Glad tidings from yellow fever research

303. Geographic variation among St. Louis encephalitis virus strains in the viremic responses of avian hosts

305. Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues

306. Investigations of the vertebrate hosts of eastern equine encephalitis during an epizootic in Michigan, 1980

307. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis

308. Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases

309. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence

310. Epidemiologic investigations of the 1969 epidemic of Venezuelan encephalitis in Ecuador

311. LeDantec virus: identification as a rhabdovirus associated with human infection and formation of a new serogroup

312. A field study on the effects of Fort Morgan virus, an arbovirus transmitted by swallow bugs, on the reproductive success of cliff swallows and symbiotic house sparrows in Morgan County, Colorado, 1976

313. Genetic heterogeneity among Saint Louis encephalitis virus isolates of different geographic origin

314. Variation in infectivity of Saint Louis encephalitis viral strains for Culex pipiens quinquefasciatus (Diptera: Culicidae)

315. Togaviridae and Flaviviridae: The Alphavirases and Flaviviruses

316. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas

317. Arbovirus infections among laboratory personnel in Ibadan, Nigeria

318. Aedes albopictus, an exotic mosquito vector in the United States

319. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1

320. Viruses isolated from reptiles: identification of three new members of the family Rhabdoviridae

321. Necrotizing myocarditis in mice infected with Western equine encephalitis virus: Clinical, electrocardiographic, and histopathologic correlations

322. Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. I. Description of the area and serological survey of humans and other vertebrate hosts

323. Labile serum factor and its effect on arbovirus neutralization

324. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination

325. Effects of thorotrast on humoral antibody, viral multiplication, and interferon during infection with St. Louis encephalitis virus in mice

327. Isolation of St. Louis Encephalitis Virus from Adult Dermacentor Variabilis (Acari: Ixodidae)

328. Type B hepatitis and yellow fever infections in West Africa

329. St Louis Encephalitis

331. A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

332. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease

333. Yellow fever resurgence: An avoidable crisis?

334. High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission

335. A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants

336. Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile

337. Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species

338. rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

340. Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

341. The brewing storm

342. ‘One Health’ in Action Series: Nos 1-8

343. Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model

345. Lack of Transmission of Vaccinia Virus

346. In Memoriam: Robert Emmons Kissling (1923–2013)

347. The Arboviruses : Epidemiology and Ecology

348. New Concepts for Vaccines

Catalog

Books, media, physical & digital resources